Whalesbook
Caprihans India Limited has increased its paid-up equity share capital to ₹15.91 crore after allotting 330,000 shares to its promoter, Bilcare Limited. Bilcare completed the warrant conversion by paying the remaining ₹4.95 crore.
Transaction Details
Caprihans India announced it allotted 330,000 equity shares to promoter Bilcare Limited, completing the conversion of 330,000 warrants. Bilcare paid the final ₹4.95 crore, completing the ₹6.60 crore total issue price. This moves Caprihans India's paid-up equity share capital from ₹15.58 crore to ₹15.91 crore. The Board of Directors approved this on March 25, 2026.
Why this matters
The share allotment is a direct capital injection from promoter Bilcare Limited into Caprihans India. It reinforces Bilcare's control and continues its process of consolidating its stake in the subsidiary.
Background
Caprihans India, a PVC film maker, is a subsidiary of Bilcare. In November 2024, Bilcare received shareholder approval to buy up to 4.8 million warrants in Caprihans at ₹200 each. Before this latest allotment, Bilcare had already converted 1.49 million warrants in January 2025 and another 300,000 warrants on March 20, 2026. These earlier conversions increased Bilcare's stake, reaching 57.81% by March 23, 2026.
What changes now
- Caprihans India's paid-up equity share capital has increased, reflecting the conversion of warrants into shares.
- Promoter Bilcare Limited's shareholding has been further consolidated, reinforcing its control.
- The capital raised contributes to the company's financial resources.
Risks to watch
Caprihans India reported a net loss of ₹62.18 crore for FY25. The company has a significant debt burden, with a Debt/Equity ratio of 176.33% (TTM), stemming from substantial past borrowing. Ongoing operational challenges and past defaults by the promoter, though resolved, could pose broader risks.
Peer comparison
Caprihans India operates in the competitive packaging materials sector. Its peers include Jindal Poly Films Ltd., Polyplex Corporation Ltd., and Uflex Ltd., which also focus on plastic films and packaging solutions.
Key Financial Metrics
- The company reported a net loss of ₹62.18 crore for the fiscal year ending March 2025 (Standalone).
- Revenue stood at ₹751.51 crore for FY25 (Standalone).
- Caprihans India has a high Debt/Equity ratio of 176.33% (TTM).
What to track next
- Monitor further conversions of the remaining 26,80,000 warrants held by Bilcare Limited.
- Track Caprihans India's future financial performance, particularly its profitability and debt management.
- Observe any disclosures regarding the utilisation of funds raised and strategic initiatives.
- Keep an eye on updated shareholding patterns reflecting the new allotment.